Phathom Pharmaceuticals
PHAT
trading on NASDAQ
since 2019
$8.99
(Δ 91.04%)
+$4.27 since open
Phathom Pharmaceuticals is a biopharmaceutical company focused on developing innovative treatments for various medical conditions, including metabolic and rare diseases, with a strong pipeline of therapeutic candidates in clinical development.
| type | open | high | low |
market cap |
volume |
|---|---|---|---|---|---|
| stock | $4.80 | $12.32 | $4.71 | $296.71M | 53.36M |
| eps | p/e | p/s |
operating margin |
profit margin |
yield |
| -$1.31 | n/a | 22.69 | -276.53% | -330.71% | 0% |